Adaptive robust control of cancer chemotherapy with extended Kalman filter observer
Author:
Publisher
Elsevier BV
Subject
Health Informatics
Reference34 articles.
1. Cancer treatment and survivorship statistics;Siegel;CA: Cancer J Clin,2012
2. Reduction of cytotoxicity to normal tissues by new regimens of cell-cycle phase-specific drugs;Agur;J Math Biosci,1998
3. Multidrug resistance: can new drugs help chemotherapy score against cancer?;Goldman;J Natl Cancer Inst,2003
4. DNA-damaging agents in cancer chemotherapy: serendipity and chemical biology;Cheung-Ong;Chem Biol,2013
5. Microtubules as a target for anticancer drugs;Jordan;Nat Rev Cancer,2004
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Robust Control for Cancer Chemotherapy Through Time Delayed Estimation Philosophy;IEEE Access;2024
2. Non-linear kernel-based error function for extended Kalman filter oriented robust control of cancer chemotherapy;Multimedia Tools and Applications;2023-07-24
3. A New Fuzzy Reinforcement Learning Method for Effective Chemotherapy;Mathematics;2023-01-16
4. Artificial Intelligence in Airway Management;Artificial Intelligence in Anesthesiology;2023
5. State/Parameter Identification in Cancerous Models Using Unscented Kalman Filter;Cybernetics and Systems;2022-12-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3